Oncostellae
Entity

  • Oncostellae

    Created in 2013


  • Up & running (A)
    Existing signals show a regular activity

  • Social networks

    1,494

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Rúa de Lope Gómez de Marzoa, 15706 Santiago de Compostela, A Coruña, Spain

    Santiago de Compostela

    Spain

  • Employees

    Scale: 2-10

    Estimated: 10

  • Engaged corporates

    0
    0 0

  • Added in Motherbase

    11 months, 4 weeks ago
Description
  • Value proposition

    Novel small-molecule drugs in immunology, fibrosis and women health

    Clinical-stage biotech company founded by serial entrepreneurs and owned by private & institutional investors. Discovery and development of new chemical entities with strong IP and worldwide rights targeting indications with high unmet medical need in immunology, fibrosis and women health.

    Medicinal Chemistry, in vitro Pharmacology, Drug Discovery and Development, Inflammation and autoimmune diseases, IP generation, IBD, Ulcerative Colitis, Crohn's disease, Fibrosis, and Uterine fibroids

  • Oncostellae - Biotech startup

    Oncostellae is a biotechn startup developing small-molecule drugs with innovative scaffolds (NCEs) that modulate clinically validated therapeutic targets in oncology and inflammatory/autoimmune diseases.

    • https://oncostellae.com/
Corporate interactions
Corporate TypeTweets Articles
No interactions
Similar entities
Last news
Show all articles
Social network dynamics